Branded Legacy Inc

PINK:BLEG USA Drug Manufacturers - Specialty & Generic
Market Cap
$698.53K
Market Cap Rank
#42073 Global
#13645 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.66
About

Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc. was incorporated in 1981 and is headquartered in Melbourne, Florida.

Branded Legacy Inc (BLEG) - Net Assets

Latest net assets as of June 2025: $1.30 Million USD

Based on the latest financial reports, Branded Legacy Inc (BLEG) has net assets worth $1.30 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.33 Million) and total liabilities ($2.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $1.30 Million
% of Total Assets 39.16%
Annual Growth Rate 45.83%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 1876.35

Branded Legacy Inc - Net Assets Trend (2015–2024)

This chart illustrates how Branded Legacy Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Branded Legacy Inc (2015–2024)

The table below shows the annual net assets of Branded Legacy Inc from 2015 to 2024.

Year Net Assets Change
2024-12-31 $1.79 Million +228.03%
2023-12-31 $-1.40 Million +11.51%
2022-12-31 $-1.58 Million +15.65%
2021-12-31 $-1.87 Million -20.82%
2020-12-31 $-1.55 Million -4293.86%
2019-12-31 $36.93K +222.70%
2018-12-31 $11.44K +108.99%
2017-12-31 $-127.35K -223.87%
2016-12-31 $102.81K +71.58%
2015-12-31 $59.92K --

Equity Component Analysis

This analysis shows how different components contribute to Branded Legacy Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 9760300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $608.04K 34.00%
Other Comprehensive Income $1.05 Million 58.71%
Other Components $277.46K 15.52%
Total Equity $1.79 Million 100.00%

Branded Legacy Inc Competitors by Market Cap

The table below lists competitors of Branded Legacy Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Branded Legacy Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -1,396,618 to 1,788,124, a change of 3,184,742.
  • Net loss of 108,431 reduced equity.
  • Other comprehensive income increased equity by 3,843,087.
  • Other factors decreased equity by 549,914.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-108.43K -6.06%
Other Comprehensive Income $3.84 Million +214.92%
Other Changes $-549.91K -30.75%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Branded Legacy Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.38x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.02x to 0.38x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 $0.04 $0.00 x
2017-12-31 $-0.07 $0.00 x
2018-12-31 $0.01 $0.00 x
2019-12-31 $0.02 $0.00 x
2020-12-31 $-0.03 $0.00 x
2021-12-31 $-0.99 $0.00 x
2022-12-31 $-0.01 $0.00 x
2023-12-31 $0.00 $0.00 x
2024-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Branded Legacy Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -6.06%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -224.04%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 1.87x
  • Recent ROE (-6.06%) is above the historical average (-455.58%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -113.80% -403.47% 0.28x 1.01x $-74.18K
2016 -0.24% -128.27% 0.00x 2.31x $-10.53K
2017 0.00% -86.67% 9.30x 0.00x $-112.73K
2018 -3214.32% -98.79% 6.94x 4.69x $-368.96K
2019 -1221.41% -74.61% 2.02x 8.09x $-454.72K
2020 0.00% -296.61% 0.67x 0.00x $-143.60K
2021 0.00% -488.37% 0.53x 0.00x $-126.69K
2022 0.00% -75.95% 1.34x 0.00x $-5.86K
2023 0.00% 4614.24% 0.44x 0.00x $3.97 Million
2024 -6.06% -224.04% 0.01x 1.87x $-287.24K

Industry Comparison

This section compares Branded Legacy Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Branded Legacy Inc (BLEG) $1.30 Million -113.80% 1.55x $56.91K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million